Review ArticleA meta-analysis demonstrates no significant differences between patient and population preferences
Introduction
Cost-effectiveness and cost-utility analyses of health care interventions are increasingly used as instruments to allocate scarce resources in health care. The results of these analyses are summarized in Quality Adjusted Life Years (QALY) League Tables (QLTs). Whether these tables are appropriate decision-making tools has been extensively discussed in the literature [1], [2], [3]. One of the main shortcomings of these QLTs is that it is not always clear whether preferences are elicited from patients or from the general population. In addition, it is largely unknown whether it matters if one uses patient or population preferences [4], [5].
Preferences are quantitative expressions for certain health states and are used to calculate QALYs. They reflect the desirability of certain health states [6]. Methods for assigning preferences to health states may be choice based [e.g., Standard Gamble (SG), Time Trade-Off (TTO)] or nonchoice-based [e.g., Visual Analogue Scale (VAS), Rating Scale] [7]. The Health Utility Index (HUI), the Quality of Well-Being Scale (QWB), and the EuroQol-5D (EQ-5D) are multiattribute descriptive classification systems for generic health states with preference scores [7], [8], [9]. These instruments are suitable for economic evaluations [6], [10].
Preferences can be elicited from the patient him/herself. For some diseases, where the patient may be unable to answer questions (e.g., dementia or stroke) the judgments of physicians, other health care professionals or caregivers, so-called proxies, are used to elicit preferences. Since the Panel on Cost-Effectiveness recommended using the societal perspective for costs and effects, the general population can also be used [10]. However, the literature is ambiguous about the question whose preferences count [10], [11]. The conclusion that patient preferences are higher than [12], [13] or equal to [14], [15] population preferences is mostly derived from single articles or narrative reviews [15], [16]. These articles report mixed findings, and are confusing to those seeking guidance on decision making [17]. A meta-analytic approach may help to overcome this problem. To our knowledge, there has so far not been any attempt to summarize the literature quantitatively. The goal of our review was to analyze the difference between directly elicited patient preferences and directly elicited preferences from the general population. In the present study we applied a framework [18] to systematically identify the goals of the decision-making processes. We concentrated on the goal of guiding the decision-making process used to allocate resources. The relevant preferences were classified into the actual preferences of patients and the hypothetical preferences of the general population. The second goal of our review was to assess the bias of having experienced the disease, for which we compared the preferences of patients and the population for hypothetical health states.
Because preference studies are mostly observational studies, it is important to account for potential sources of heterogeneity [19]. As mentioned above, various methods can be used to elicit preferences and to explain the differences between patient and population preferences. Preferences can be attached to disease-specific or generic health states, or health state profiles. Hence, a health state assessment was included as a possible source of heterogeneity, as was the way preferences are assessed. External factors, such as gender, age, educational level, and type of disease (chronic, contagious, or risk factors for disease) were added [11], [15], [20], [21]. The third goal of this review was to assess the effects of different sources of heterogeneity on patient and population preferences.
Section snippets
Data sources
The literature search covered the computerized databases MEDLINE (1966–March 2005), ECONLIT (1969–March 2005), PsychINFO (1887–March 2005), CINAHL (1982–March 2005), EMBASE (1989–March 2005), and the Cochrane Library (1996–March 2005), which holds a collection of seven databases. The search was restricted to adults (≥18 years). References cited in published original and review papers were examined until no further articles were identified. No language restrictions were applied. The search
Study characteristics
Table 1 shows the characteristics of the 78 independent estimates. VAS was used to assess preferences in 52.6% of the estimates, while TTO and SG were used in 16.7% of the estimates, and EQ-5D in 65.4%. HUI and QWB were not used to assess preferences for either actual or hypothetical patient and population preferences.
To assess the severity of the health states, 23.1% of the estimates used disease-specific instruments, whereas 46.2% used generic instruments and 65.4% used a health state profile.
Conclusion
Our meta-analyses demonstrate that patient preferences for actual health state do not differ significantly from population preferences for hypothetical health state. This finding suggests that patient and population preferences can both be used to allocate resources. Moreover, the meta-analyses revealed that a variety of parameters act as sources of heterogeneity, including preference elicitation methods, health state assessment methods, study assessment methods and population characteristics.
References (118)
- et al.
Cost-effectiveness league tables: more harm than good?
Soc Sci Med
(1993) Measurement of health state utilities for economic appraisal
J Health Econ
(1986)- et al.
The utility of different health states as perceived by the general public
J Chronic Dis
(1978) - et al.
Methodology for measuring health-state preferences—III: population and context effects
J Clin Epidemiol
(1989) - et al.
Methodology for measuring health-state preferences—II: scaling methods
J Clin Epidemiol
(1989) - et al.
The measurement iterative loop: a framework for the critical appraisal of need, benefits and costs of health interventions
J Chronic Dis
(1985) Methods for quality adjustment of life years
Soc Sci Med
(1992)- et al.
Health related quality of life in patients with total hip or knee replacement
Arch Phys Med Rehabil
(1999) The validity of using health state indexes in measuring the consequences of traffic injury for public health
Soc Sci Med
(1995)- et al.
Cost analysis and quality of life assessment comparing patients undergoing autologous peripheral blood stem cell transplantation or autologous bone marrow transplantation for refractory or relapsed non-Hodgkin's lymphoma or Hodgkin's disease. a prospective randomised trial
Eur J Cancer
(2001)
Health status and hypertension: a population-based study
J Clin Epidemiol
Assessing health-related quality of life pre- and post-liver transplantation: a prospective multicenter study
Liver Transplant
Health-related quality of life with coronary heart disease prevention and treatment
J Clin Epidemiol
Quality of life in long-term home enteral nutrition patients
Clin Nutr
QALY league tables: handle with care
Health Econ
Some guidelines on the use of cost effectiveness league tables
BMJ
Whose quality of life? A commentary exploring discrepancies between health state evaluations of patients and the general public
Qual Life Res
Whose quality of life? or Whose decision?
Qual Life Res
Methods for the Economic Evaluation of Health Care Programmes
EuroQol—a new facility for the measurement of health-related quality of life
Health Policy
A general health policy model: update and applications
Health Serv Res
Cost-effectiveness in health and medicine
Sensitivity and perspective in the valuation of health status: whose values count?
Health Econ
Whose utilities for decision analysis?
Med Decis Making
Weights for scoring the quality of well-being instrument among rheumatoid arthritics. A comparison to general population weights
Med Care
The time trade-off technique: how do the valuations of breast cancer patients compare to those of other groups?
Qual Life Res
Spurious precision? Meta-analysis of observational studies
BMJ
Valuing health-related quality of life. A review of health state valuation techniques
Pharmacoeconomics
Validity of Euroqol—a generic health status instrument—in patients with rheumatoid arthritis. Economic and Health Outcomes Research Group
Br J Rheumatol
Relationship between health status and utility measures in older claudicants
Qual Life Res
Economic evaluation of aquatic exercise for persons with osteoarthritis
Med Care
The relationship between health related quality of life and disease activity and damage in systemic lupus erythematosus
J Rheumatol
Is intensive care worth it? An assessment of input and outcome for the critically ill
Crit Care Med
Assessing quality of life in people with multiple sclerosis
Disabil Rehabil
Using the ICSOoL to measure the impact of lower urinary tract symptoms on quality of life: evidence from the ICS-“BPH” Study. International Continence Society—benign prostatic hyperplasia
Br J Urol
Eliciting EuroQol descriptive data and utility scale values from inpatients. A feasibility study
Pharmacoeconomics
Stroke recovery profile and the modified Rankin assessment
Neuroepidemiology
Preference for fractures and other glucocorticoid-associated adverse effects among rheumatoid arthritis patients
Med Decis Making
A multi-attribute model of prostate cancer patient's preferences for health states
Qual Life Res
The psychometric properties of patient preferences in osteoporosis
J Rheumatol
Unstable preferences: a shift in valuation or an effect of the elicitation procedure?
Med Decis Making
Assessing the health of the nation. The predictive validity of a preference-based measure and self-rated health
Med Care
Comparing the performance of health status measures for healthy older adults
J Am Geriatr Soc
A comparison of United Kingdom and Spanish general population time trade-off values for EQ-5D health states
Med Decis Making
Variations in self-reported health status: results from a New Zealand survey
N Z Med J
The weighting exercise for the Swedish version of the EuroQol
Health Econ
Linking health-related quality-of-life indicators to large national data sets
Pharmacoeconomics
Description and valuation of health-related quality of life among the general public in Japan by the EuroQol
J Med Invest
Comparison of three measures of quality of life outcome in the evaluation of continuous positive airways pressure therapy for sleep apnoea
J Sleep Res
Health state valuations from the general public using the visual analogue scale
Qual Life Res
Cited by (47)
Carer Social Care-Related Quality of Life Outcomes: Estimating English Preference Weights for the Adult Social Care Outcomes Toolkit for Carers
2019, Value in HealthCitation Excerpt :The study was reviewed and approved by the University of Kent SRC Research Ethics Committee, [REF SR CEA 149]. We estimated preferences of a general population sample (rather than a service user or carer sample), which is a common approach in the estimation of preference weights.36,37 This is because it is the public at large whose views are relevant, where services are publicly-funded, and whose data are used to make decisions about resource allocations.38
Estimation of Health Utilities Based on the Response to Treatment in Atopic Dermatitis: a Population-based Study
2019, Clinical TherapeuticsCitation Excerpt :However, when patients adapt to their disease, they might report higher utility values than the general population.18 In some cases, patients evaluate the utility weights higher than the general population; in general, however, it is known that patients evaluate utilities lower than or similar to the general population.19–21 Gandjour22 noted that the heath utility values of patients with chronic disease could be overestimated because patients might have adapted to their health status.
Questioning the differences between general public vs. patient based preferences towards EQ-5D-5L defined hypothetical health states
2019, Health PolicyCitation Excerpt :Another limitation of the use of patient preferences is the inability to assess rare adverse treatment events due to a lack of patients with relevant experience [5] and patients being able to answer [12,13]. The scientific discussion on whether QALYs should comprise patient preferences as opposed to community preferences is still ongoing [2,4,5,11–26]. Several studies provide empirical evidence on the differences between patient and general public preferences.
Quantifying Worry in the Face of Uncertainty: Radiation Exposure from Medical Imaging
2017, Journal of Medical Imaging and Radiation Sciences